📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Zalicus

1.1 - Company Overview

Zalicus Logo

Zalicus

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery and development of novel-target pain therapies, including a calcium channel modulator for chronic and acute inflammatory pain.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Zalicus

Psyence Biomed Logo

Psyence Biomed

HQ: Canada Website
  • Description: Provider of nature-derived psilocybin-based psychedelic medicines focused on mental health disorders in palliative care. Conducts Phase IIb clinical trials of natural psilocybin for Adjustment Disorder with psychotherapy and varied dosages, and plans a clinical trial for Alcohol Use Disorder with a focus on Substance Use Disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Psyence Biomed company profile →
AskBio Logo

AskBio

HQ: United States Website
  • Description: Provider of AAV-based gene therapies for genetic disorders and rare diseases, offering proprietary AAV technology, manufacturing capabilities, and in-house clinical programs. Pipeline includes AB-1002 for advanced heart failure (GenePHIT Phase 2), ACT-101 for late-onset Pompe disease, and NAN-101 for congestive heart failure, plus research on AAV immune responses and episome configuration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AskBio company profile →
Remedy Pharmaceuticals Logo

Remedy Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage small molecule drug therapies for acute central nervous system disorders, developing treatments that target NCCa-ATP channels in traumatic brain injury, stroke, and spinal cord injury, including RP-1127, an intravenous glyburide inhibitor acting through type-1 sulfonylurea antagonism.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Remedy Pharmaceuticals company profile →
Vitro Biopharma Logo

Vitro Biopharma

HQ: United States Website
  • Description: Provider of stem cell therapy, cell lines, and cell culture media, including AlloRx Stem Cell therapy from Wharton’s jelly–derived MSCs for autoimmune and inflammatory disorders; MSC-Gro specialty media for MSC growth and expansion; research-grade cancer-associated and native fibroblasts; human umbilical cord and placenta-derived MSC lines; and MSC-Gro formulations (low serum, serum-free, CAF-specific).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vitro Biopharma company profile →
Predix Pharmaceuticals Logo

Predix Pharmaceuticals

HQ: United States Website
  • Description: Provider of drug discovery and development leveraging a novel 3D Discovery and Optimization Engine for GPCR drug candidates. Utilizes the proprietary PREDICT algorithm to computer-model the 3D structure of any GPCR target and advance novel compounds into the clinic.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Predix Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Zalicus

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Zalicus

2.2 - Growth funds investing in similar companies to Zalicus

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Zalicus

4.2 - Public trading comparable groups for Zalicus

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Zalicus

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Zalicus

What does Zalicus do?

Zalicus is a provider of discovery and development of novel-target pain therapies, including a calcium channel modulator for chronic and acute inflammatory pain.

Who are Zalicus's competitors?

Zalicus's competitors and similar companies include Psyence Biomed, AskBio, Remedy Pharmaceuticals, Vitro Biopharma, and Predix Pharmaceuticals.

Where is Zalicus headquartered?

Zalicus is headquartered in United States.

How many employees does Zalicus have?

Zalicus has 1,000 employees 🔒.

When was Zalicus founded?

Zalicus was founded in 2010 🔒.

What sector and industry vertical is Zalicus in?

Zalicus is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Zalicus

Who are the top strategic acquirers in Zalicus's sector and industry

Top strategic M&A buyers and acquirers in Zalicus's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Zalicus?

Top strategic M&A buyers groups and sectors for Zalicus include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Zalicus's sector and industry vertical

Which are the top PE firms investing in Zalicus's sector and industry vertical?

Top PE firms investing in Zalicus's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Zalicus's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Zalicus's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Zalicus's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Zalicus include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Zalicus's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Zalicus?

The key public trading comparables and valuation benchmarks for Zalicus include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Zalicus for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Zalicus with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Zalicus's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Zalicus with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Zalicus's' sector and industry vertical?

Access recent funding rounds and capital raises in Zalicus's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Zalicus